National Health Investors Stock Performance
| NHI Stock | USD 73.81 0.89 1.19% |
National Health has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Health is expected to be smaller as well. National Health Investors right now secures a risk of 1.44%. Please verify National Health Investors expected short fall, and the relationship between the value at risk and daily balance of power , to decide if National Health Investors will be following its current price movements.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in National Health Investors are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady technical indicators, National Health may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Actual Historical Performance (%)
One Day Return 1.85 | Five Day Return (0.24) | Year To Date Return 9.24 | Ten Year Return 4.72 | All Time Return 266.54 |
Forward Dividend Yield 0.0491 | Payout Ratio | Forward Dividend Rate 3.6 | Dividend Date 2025-05-02 | Ex Dividend Date 2025-03-31 |
1 | Disposition of 18334 shares by Kevin Pascoe of National Health at 53.41 subject to Rule 16b-3 | 01/03/2025 |
2 | National Health Investors Inc Announces Fourth Quarter 2024 Earnings Release and ... | 01/22/2025 |
3 | Disposition of 10000 shares by James Jobe of National Health at 54.73 subject to Rule 16b-3 | 01/23/2025 |
| National Health dividend paid on 29th of January 2025 | 01/29/2025 |
4 | Disposition of 18334 shares by John Spaid of National Health at 69.2 subject to Rule 16b-3 | 02/14/2025 |
5 | Disposition of 267 shares by John Spaid of National Health at 68.96 subject to Rule 16b-3 | 02/21/2025 |
6 | National Health Investors Tops Q4 FFO and Revenue Estimates | 02/25/2025 |
7 | National Health Investors Q4 Earnings How Key Metrics Compare to Wall Street Estimates | 02/26/2025 |
8 | National Health Investors Inc Q4 2024 Earnings Call Highlights Strong NOI Growth and ... | 02/27/2025 |
9 | Decoding National Health Investors Inc A Strategic SWOT Insight | 02/28/2025 |
10 | Acquisition by Robert Adams of 10000 shares of National Health at 73.34 subject to Rule 16b-3 | 03/03/2025 |
11 | Acquisition by Kevin Pascoe of 5500 shares of National Health subject to Rule 16b-3 | 03/05/2025 |
12 | Acquisition by Kristin Gaines of 4000 shares of National Health subject to Rule 16b-3 | 03/07/2025 |
13 | Charles Schwab Investment Management Inc. Acquires 24,462 Shares of National Health Investors, Inc. - Defense World | 03/13/2025 |
14 | NHI Announces 46.3 Million Senior Housing Investment | 03/17/2025 |
15 | Is National Health Investors Seeing Increased Institutional Confidence | 03/18/2025 |
| Begin Period Cash Flow | 24.6 M |
National |
National Health Relative Risk vs. Return Landscape
If you would invest 6,846 in National Health Investors on December 25, 2024 and sell it today you would earn a total of 535.00 from holding National Health Investors or generate 7.81% return on investment over 90 days. National Health Investors is generating 0.1357% of daily returns assuming volatility of 1.4372% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than National, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National Health Investors, and traders can use it to determine the average amount a National Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0944
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | NHI | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.44 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average National Health is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Health by adding it to a well-diversified portfolio.
National Health Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National Health, and National Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0463 | ||||
| Profit Margin | 0.41 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.47 B | ||||
| Shares Outstanding | 45.69 M | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.45 X | ||||
| Price To Sales | 10.17 X | ||||
| Revenue | 257.05 M | ||||
| Gross Profit | 324.42 M | ||||
| EBITDA | 264.16 M | ||||
| Net Income | 136.64 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.15 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 207.77 M | ||||
| Earnings Per Share | 3.13 X | ||||
| Market Capitalization | 3.41 B | ||||
| Total Asset | 2.61 B | ||||
| Retained Earnings | 2.6 B | ||||
| Working Capital | (17.44 M) | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
About National Health Performance
By evaluating National Health's fundamental ratios, stakeholders can gain valuable insights into National Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.08 | |
| Return On Capital Employed | 0.10 | 0.09 | |
| Return On Assets | 0.05 | 0.08 | |
| Return On Equity | 0.10 | 0.10 |
Things to note about National Health Investors performance evaluation
Checking the ongoing alerts about National Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National Health Investors help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 70.0% of the company shares are owned by institutional investors | |
| On 29th of January 2025 National Health paid $ 0.9 per share dividend to its current shareholders | |
| Latest headline from kalkinemedia.com: Is National Health Investors Seeing Increased Institutional Confidence |
- Analyzing National Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Health's stock is overvalued or undervalued compared to its peers.
- Examining National Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Health's stock. These opinions can provide insight into National Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |